Regeneron Pharmaceuticals, Inc.(REGN)
đ Upcoming Dividend Payout
$0.88per Share
Regeneron Pharmaceuticals, Inc. will be allocating a dividend of $0.88 per share to its investors on the specified date of June 6, 2025.
Ex-Dividend Date:May 20, 2025
đ Dividend Highlights
Previous Payout History
1 payouts shown| Pay Date | Amount Per Share |
|---|---|
| March 20, 2025 | $0.88 |
About Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc. is a leading biotechnology company founded in 1988 by Leonard Schleifer and George Yancopoulos. Headquartered in Tarrytown, New York, the company specializes in developing and commercializing medicines for serious diseases. Known for its innovative research and development, Regeneron focuses on areas such as ophthalmology, oncology, immunology, and more. As of 2023, Leonard Schleifer serves as the CEO, continuing to steer the company toward groundbreaking medical advancements. Regeneron achieved significant recognition for its development of treatments such as EYLEA for eye diseases and its COVID-19 antibody cocktail. With a commitment to scientific excellence and patient care, Regeneron has become a respected name in the biotechnology sector, boasting over $12 billion in revenue in recent years.
AbbVie Inc.(ABBV)
Amgen Inc.(AMGN)
Eli Lilly and Company(LLY)
Gilead Sciences, Inc.(GILD)
Intellia Therapeutics, Inc.(NTLA)
Merck & Co., Inc.(MRK)
Moderna, Inc.(MRNA)
Pfizer Inc.(PFE)
Vertex Pharmaceuticals Incorporated(VRTX)
Vir Biotechnology, Inc.(VIR)Dividend data last updated:Wed, 21 May 2025 02:31:08 GMT. Financial data is indicative and provided for informational purposes only.